Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 4/20 | 0.44 |
| ▸ | NOS3 | P29474 | 1/20 | 0.44 |
| ▸ | NOS1 | P29475 | 1/20 | 0.44 |
| ▸ | NOS2 | P35228 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 2/20 | 0.42 |
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9217746 | 0.90 | MAOB (0.44) | IDO1NOS3NOS1NOS2MAOB | |
| SCHEMBL23138287 | 0.89 | IDO1 (0.38) | IDO1NOS3NOS1NOS2MAOB | |
| SCHEMBL28359780 | 0.84 | PAM (0.55) | IDO1NOS3NOS1NOS2MAOB | |
| SCHEMBL2074627 | 0.83 | IDO1 (0.44) | IDO1NOS3NOS1NOS2MAOB | |
| SCHEMBL28420190 | 0.82 | TP53 (0.41) | IDO1NOS3NOS1NOS2MAOB | |
| SCHEMBL28902312 | 0.80 | CYP2D6 (0.44) | IDO1NOS3NOS1NOS2MAOB | |
| SCHEMBL23088675 | 0.80 | EGFR (0.39) | IDO1NOS3NOS1NOS2MAOB | |
| SCHEMBL1679996 | 0.79 | IDO1 (0.41) | IDO1NOS3NOS1NOS2MAOB | |
| SCHEMBL10978005 | 0.79 | CYP1A2 (0.42) | IDO1NOS3NOS1NOS2MAOB | |
| SCHEMBL11384559 | 0.79 | CYP1A2 (0.42) | IDO1NOS3NOS1NOS2MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 236 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025133616-A1 | CONJUGATED POLYMER NANOPARTICLE BIOSENSORS | STREAM BIO LTD (GB) | 2025-06-26 | — | — | WO | claimed |
| US-8980473-B2 | Anode and battery | SONY CORPORATION (JP) | 2015-03-17 | — | — | US | claimed |
| US-8609258-B2 | Light emitting devices and compositions | NITTO DENKO CORPORATION (JP) | 2013-12-17 | — | — | US | claimed |
| US-20120305895-A1 | LIGHT EMITTING DEVICES AND COMPOSITIONS | NITTO DENKO CORPORATION (JP) | 2012-12-06 | — | — | US | claimed |
| US-20120269736-A1 | MICELLAR COMPOSITIONS FOR USE IN BIOLOGICAL APPLICATIONS | KING'S COLLEGE LONDON (GB) | 2012-10-25 | — | — | US | claimed |
| US-8179589-B2 | Methods and compositions for improved electrophoretic display performance | SIPIX IMAGING, INC. (US) | 2012-05-15 | — | — | US | claimed |
| WO-2011039535-A2 | MICELLAR COMPOSITIONS FOR USE IN BIOLOGICAL APPLICATIONS | KING'S COLLEGE LONDON (GB) | 2011-04-07 | — | — | WO | claimed |
| US-20100301280-A1 | METHODS AND COMPOSITIONS FOR IMPROVED ELECTROPHORETIC DISPLAY PERFORMANCE | SIPIX IMAGING INC. | 2010-12-02 | — | — | US | claimed |
| US-20090066234-A1 | LIGHT EMITTING DEVICES AND COMPOSITIONS | NITTO DENKO CORPORATION (JP) | 2009-03-12 | — | — | US | claimed |
| WO-2009006550-A1 | LIGHT EMITTING DEVICES AND COMPOSITIONS | NITTO DENKO CORPORATION (JP) | 2009-01-08 | — | — | WO | claimed |
| EP-1529242-A2 | PROTECTING LAYER WITH ADDITIVES FOR ELECTROPHORETIC DISPLAY, METHOD OF PROVIDING SUCH LAYER, AND ELECTROPHORETIC DISPLAY WITH SUCH A LAYER | Sipix Imaging, Inc. (US) | 2005-05-11 | — | — | EP | claimed |
| US-20040085619-A1 | Novel Methods and compositions for improved electrophoretic display performance | SIPIX IMAGING, INC. | 2004-05-06 | — | — | US | claimed |
| WO-2004010206-A2 | PROTECTING LAYER WITH ADDITIVES FOR ELECTROPHORETIC DISPLAY, METHOD OF PROVIDING SUCH LAYER, AND ELECTROPHORETIC DISPLAY WITH SUCH A LAYER | SIPIX IMAGING, INC. (US) | 2004-01-29 | — | — | WO | claimed |
| WO-2025133616-A1 | CONJUGATED POLYMER NANOPARTICLE BIOSENSORS | STREAM BIO LTD (GB) | 2025-06-26 | — | — | WO | disclosed |
| US-10786683-B2 | Light-emitting devices for wound healing | NITTO DENKO CORPORATION (JP) | 2020-09-29 | — | — | US | disclosed |
| US-9978953-B2 | Substituted biphenyl compounds for use in light-emitting devices | NITTO DENKO CORPORATION (JP) | 2018-05-22 | — | — | US | disclosed |
| US-20050007648-A1 | Methods and compositions for improved electrophoretic display performance | E INK CORPORATION | 2005-01-13 | — | — | US | disclosed |
| US-20040085619-A1 | Novel Methods and compositions for improved electrophoretic display performance | SIPIX IMAGING, INC. | 2004-05-06 | — | — | US | disclosed |
| US-20030035917-A1 | Image making medium | HYMAN SYDNEY (US) | 2003-02-20 | — | — | US | disclosed |
| US-4886627-A | Conductive structures in polymers | VEB METALLURGIEELEKTRONIK LEIPZIG (DD) | 1989-12-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090066234-A1 | LIGHT EMITTING DEVICES AND COMPOSITIONS | MAP1LC3A, MAP1LC3C, CRY1 | IDO1 273/4885NOS3 2115/4885NOS1 1729/4885 |
| US-20120305895-A1 | LIGHT EMITTING DEVICES AND COMPOSITIONS | ILK, CRY1, IK | IDO1 393/4885NOS3 2782/4885NOS1 1214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.